Traditionally, valvular heart disease has been treated with surgical repair or replacement. Over the last several years, however, there have been important advances in concepts, tools, techniques, and patient selection in the treatment of valvular heart disease using nonsurgical procedures.
Transcatheter valve intervention offers the potential to reduce procedural morbidity, mortality, and cost of surgical valve replacement or repair while also accelerating patient recovery.
TVT 2014 Offers:
- Anatomical demonstrations of valvular heart disease using cadaveric hearts from the Seattle Science Foundation
- Live case transmissions
- Advanced scientific and clinical workshops
- Advanced imaging in the diagnosis and therapy of valvular heart disease
- Therapeutic options for aortic stenosis
- Diagnostic challenges of and therapeutic options for mitral valve disease
- Latest devices and new clinical targets of TAVR
- Transseptal puncture
- Repair and replacement of transcatheter mitral valve therapy
This activity is sponsored by the Cardiovascular Research Foundation and partially funded through educational grants from commercial supporters.
- Martin B. Leon, MD
- Mark Reisman, MD
- Gregg W. Stone, MD
- John G. Webb, MD